Kewaunee Scientific Co. (NASDAQ:KEQU) Director Buys $19,747.00 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) Director Keith M. Gehl bought 403 shares of the business’s stock in a transaction on Tuesday, March 18th. The stock was purchased at an average cost of $49.00 per share, with a total value of $19,747.00. Following the purchase, the director now owns 17,000 shares of the company’s stock, valued at $833,000. This represents a 2.43 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Kewaunee Scientific Price Performance

KEQU traded down $1.36 during midday trading on Tuesday, hitting $49.69. The stock had a trading volume of 31,923 shares, compared to its average volume of 22,252. The company has a market cap of $142.71 million, a P/E ratio of 7.87 and a beta of 0.71. The business has a fifty day moving average of $58.39 and a 200 day moving average of $47.80. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64. Kewaunee Scientific Co. has a 1 year low of $30.82 and a 1 year high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings data on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. The firm had revenue of $67.17 million during the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.

Analysts Set New Price Targets

Separately, StockNews.com lowered Kewaunee Scientific from a “buy” rating to a “hold” rating in a research note on Friday.

Institutional Trading of Kewaunee Scientific

Institutional investors have recently made changes to their positions in the stock. Bank of America Corp DE boosted its stake in shares of Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock valued at $28,000 after purchasing an additional 443 shares during the period. IFP Advisors Inc purchased a new stake in shares of Kewaunee Scientific during the fourth quarter valued at approximately $36,000. JPMorgan Chase & Co. boosted its stake in shares of Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock valued at $30,000 after purchasing an additional 900 shares during the period. Morgan Dempsey Capital Management LLC purchased a new stake in shares of Kewaunee Scientific during the fourth quarter valued at approximately $106,000. Finally, Barclays PLC bought a new position in shares of Kewaunee Scientific during the third quarter valued at approximately $121,000. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.